Celltrion Pharm Inc 068760
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 068760 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- KRW 91,900.00
- Day Range
- KRW 90,500.00–91,800.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 90,500.00 / KRW 90,700.00
- Market Cap
- —
- Volume/Avg
- 54,177 / 287,195
Key Statistics
- Price/Earnings (Normalized)
- 141.68
- Price/Sales
- 9.79
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.11%
Company Profile
Celltrion Pharm Inc is active in the Korean healthcare sector. Its core business includes the manufacture and sale of pharmaceuticals such as heptatonic, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs and antibiotics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 888
- Website
- http://www.celltrionph.com
Comparables
Valuation
|
Metric
|
068760
|
140410
|
293480
|
|---|---|---|---|
Price/Earnings (Normalized) | 141.68 | — | 10.35 |
Price/Book Value | 10.30 | 22.13 | 0.84 |
Price/Sales | 9.79 | 34.30 | 1.03 |
Price/Cash Flow | 91.78 | — | 7.64 |
Price/Earnings
068760
140410
293480
Financial Strength
|
Metric
|
068760
|
140410
|
293480
|
|---|---|---|---|
Quick Ratio | 1.04 | 2.17 | 0.93 |
Current Ratio | 1.46 | 2.51 | 1.82 |
Interest Coverage | 4.00 | −43.24 | — |
Quick Ratio
068760
140410
293480
Profitability
|
Metric
|
068760
|
140410
|
293480
|
|---|---|---|---|
Return on Assets (Normalized) | 3.97% | −17.65% | 6.72% |
Return on Equity (Normalized) | 6.84% | −33.91% | 8.59% |
Return on Invested Capital (Normalized) | 5.72% | −28.13% | 7.47% |
Return on Assets
068760
140410
293480
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Ptfwbjfmt | Plbcpf | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Hzncykxl | Cqwhw | $68.9 Bil | |
HLN
| Haleon PLC ADR | Rbvvmrt | Fskc | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gbqnrzyx | Lnbm | $14.7 Bil | |
VTRS
| Viatris Inc | Kclkmsgzg | Qmgg | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Zchdtpj | Bdjs | $11.9 Bil | |
CTLT
| Catalent Inc | Wpwwcnxkz | Xrmyqds | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Yrsjtxqsj | Rrvwl | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Vzqjgzj | Gzd | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Vnxqjgcbp | Bkyhzz | $3.5 Bil |